Some studies have suggested that abdominal visceral adipose tissue depth (VAD) measured by ultrasound in early pregnancy, may predict the future onset of gestational diabetes mellitus (GDM). Wheter this is true, independent of pre-pregnancy body mass index (BMi), has been debated, leading the current study. A prospective cohort study was completed, in which VAD was measured at around 14 weeks' gestation. GDM was later assessed by an oral glucose tolerance test at 24 to 28 weeks, according to the iADpSG criteria. Logistic regression analysis and receiver operating curve (Roc) analysis were used to estimate the predictive value of VAD, above and beyond pre-pregnancy BMI. 627 pregnant women were enrolled, and 518 completed the study. VAD was measured at a mean of 14.4 weeks' gestation. 87 women (16.8%) subsequently developed GDM. The unadjusted odds ratio (OR) for developing GDM was 1.99 (95% CI 1.59-2.46) per 1-cm increase in VAD. After adjusting for maternal BMI and age, the OR was 2.00 (95% CI 1.61 to 2.50). The ROC under the curve for developing GDM was higher for VAD (0.70, 95% CI 0.63 to 0.75) than for pre-pregnancy BMI (0.57 95% CI 0.50 to 0.64) (p < 0.001). In conclusion, higher VAD may better predict GDM than pre-pregnancy BMi. Gestational diabetes mellitus (GDM)-glucose intolerance, resulting in new onset in pregnancy-has emerged as a global public health concern 1. GDM is associated with potentially harmful health effects for mother and fetus 2. According to the World Health Organization (WHO), the prevalence of GDM is rising 3 , largely attributed to the worldwide epidemic of obesity, older maternal age at first pregnancy, and a change in the diagnostic criteria for GDM 4. Currently, the International Association of Diabetes recommends screening for GDM among all pregnant women, at 24 to 28 weeks' gestation, using a 75-g oral glucose tolerance test (OGTT) 5. AS this approach lacks a sufficient sensitivity and specificity 6 , a method that may improve the detection of GDM, earlier pregnancy, is desirable. Some studies have shown that abdominal visceral adipose tissue depth (VAD) measured by ultrasound in earlier pregnancy, may predict glucose intolerance, insulin resistance, metabolic syndrome, newborn weight and GDM later in pregnancy 7-13. Recently, Thaware et al. 14 showed that ultrasonography-measured VAD in early pregnancy aided in the early recognition of GDM. They reported that this method, compared with an OGTT alone, could reduce by half number of pregnant women requiring OGTT screening. However, it is not clear whether ultrasonography-measured VAD offers improve discrimination in the detection of GDM compared with simply using pre-pregnancy body mass index (BMI). Herein, we carried out a prospective cohort study among a large sample of pregnant women, to assess the role of VAD in the prediction of GDM. Methods Design and study participants. This was a prospective cohort study of pregnant women, followed from